首页|鞍山市2015-2018年高血压住院患者药物流行病学特征分析

鞍山市2015-2018年高血压住院患者药物流行病学特征分析

扫码查看
目的 分析辽宁省鞍山市2015-2018年高血压住院患者的药物流行病学特征,为进一步评估高血压患者的合理用药提供参考依据.方法 于2019年6-12月采用分层随机抽样方法通过鞍山市某3家三级甲等医院信息系统随机抽取2015、2016、2017和2018年高血压住院患者的病历资料各300份进行高血压住院患者临床特征及降压药物使用情况的分析.结果 鞍山市2015-2018年住院治疗的3 600例高血压患者中,1级高血压患者525例(14.58%),2级高血压患者1 032例(28.67%),3级高血压患者2 043例(56.75%);伴发疾病包括左心室肥厚762例(21.17%)、颈动脉硬化301例(8.36%)、冠心病514例(14.28%)、心力衰竭324例(9.00%)、缺血性脑卒中447例(12.42%)、出血性脑卒中269例(7.47%)、慢性肾脏病227例(6.31%);使用降压药物单药治疗者1 004例(27.89%),使用联合用药治疗者2 596例(72.11%);单药治疗方案中,采用钙离子拮抗剂(CCB)治疗方案的构成比最高(32.37%),其次为采用血管紧张素转化酶抑制剂(ACEI)治疗方案(20.92%);联合用药治疗方案中,采用ACEI/血管紧张素Ⅱ受体拮抗剂(ARB)+CCB+利尿剂治疗方案的构成比最高(22.65%),其次为采用ACEI/ARB+β-受体阻滞剂+CCB治疗方案(22.61%).结论 鞍山市2015-2018年高血压住院患者以3级高血压患者居多,多伴发左心室肥厚、冠心病、缺血性脑卒中等疾病,单药治疗以CCB类药物为主,联合用药治疗以ACEI/ARB+CCB+利尿剂方案为主.
Antihypertensive regimen among primary hypertension inpatients,2015-2018:an analysis on medical records of three tertiary hospitals in Anshan city
Objective To examine antihypertensive regimens among primary hypertension inpatients during 2015-2018 in Anshan city of Liaoning province for evaluating rational medication of hypertensive patients.Methods Using stratified random sampling through hospital information systems,we extracted medical records of 3 600 primary hypertension patients hospitalized at three tertiary first-class hospitals during 2015-2018(300 records/per year/per hospital)in Anshan city.The clinical characteristics and antihypertensive regimens of the inpatients were statistically analyzed.Results Of all the inpatients,525(14.58%),1 032(28.67%),and 2043(56.75%)were diagnosed with hypertension of stage Ⅰ,Ⅱ,and Ⅲ,respectively.The proportions of the inpatients having concomitant diseases were 21.17%for left ventricular hypertrophy,8.36%for carotid atherosclerosis,14.28%for coronary heart disease,9.00%for heart failure,12.42%for ischemic stroke,7.47%for hemorrhagic stroke,and 6.31%for chronic kidney disease.Among all the inpatients during the hospitalizations,1 004(27.89%)had single antihypertensive medication and 2 596(72.11%)had combined antihypertensive medication.Among the monotherapy regimens,calciumion antagonists(CCB)was the most frequently used drug in 325(32.37%)of the inpatients,followed by angiotensin converting enzyme inhibitors(ACEI)in 210(20.92%)of the inpatients.Of the inpatients with the combined regimens,588(22.65%)had the medication of ACEI/angiotensin receptor blocker(ARB)plus CCB plus diuretic and 587(22.61%)had the medication of ACEI/ARB plus β-receptor blocker plus CCB.The antihypertensive regimens differed significantly by hypertension stage among the inpatients(x2=1 922.86,P<0.001).Conclusion For the primary hypertensive patients hospitalized during 2015-2018 in Anshan city,more than a half had stage Ⅲ hypertension and left ventricular hypertrophy,coronary artery disease,and ischemic stroke were major concomitant diseases;CCB was a main monotherapy and ACEI/ARB plus CCB plus diuretic was a main combined antihypertensive regimen in the treatment of the inpatients during hospitalization.

hypertensioninpatientspharmacoepidemiologycharacterizationAnshan city

孟彤、张镇江、贾亦真、谢晶、范正悦、宗晓郁、王俊彦、贾敏、张灵健、宫建

展开 >

沈阳药科大学药物流行病与临床药物评价课题组,沈阳 110016

首都医科大学公共卫生学院,北京 100069

蚌埠医学院第一附属医院国家药物临床试验机构,蚌埠 233004

成都市第五人民医院药剂科,成都 611130

展开 >

高血压 住院患者 药物流行病学 特征 鞍山市

2024

中国公共卫生
中华预防医学会

中国公共卫生

CSTPCD北大核心
影响因子:1.404
ISSN:1001-0580
年,卷(期):2024.40(2)
  • 20